Belite Bio Inc
BLTE | NASDAQ
$174.81
+$1.41 (+0.81%)
Sep 22, 2026, 12:42 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -69.25 | -53.47 | -38.45 | -47.85 | -26.47 | -17.08 |
PEG Ratio | -0.72 | 63.63 | -0.43 | -0.83 | 0.75 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 6.96 | 13.21 | 13.45 | 14.51 | -16.91 | -13.85 |
P/FCF Ratio | -144.35 | -65.58 | -40.69 | -50.81 | -33.81 | -21.85 |
P/OCF Ratio | -145.04 | -65.92 | -40.78 | -52.56 | -34.14 | -21.95 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | 0 | 0.01 | 0.02 | -2.11 | -4.52 |
Quick Ratio | 50.02 | 24.31 | 24.76 | 20.35 | 10.66 | 26.41 |
Current Ratio | 50.02 | 24.31 | 24.76 | 20.35 | 10.66 | 26.41 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -2K | -1.27K | -801.31 | n/a | -273.48 |
Return on Equity | -10.07% | -24.79% | -34.98% | -30.48% | 64.04% | 81.75% |
Return on Assets | -9.94% | -23.76% | -33.42% | -28.57% | -52.68% | -22.35% |
Return on Invested Capital | -10.92% | -27.33% | -34.56% | -30.12% | -58.62% | -23.19% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove BLTE